Position in NKTR
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$69
-$2 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#238
of 239 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LRI Investments, LLC holds $939,258 across 57 Biotechnology names. NKTR ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
2,186 | $178,180 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,135 | $175,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
319 | $158,456 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
336 | $80,965 | |
| 5 | BHVN |
Biohaven Ltd.
|
2,572 | $38,271 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
201 | $37,643 | |
| 7 | SANA |
Sana Biotechnology, Inc.
|
10,000 | $34,900 | |
| 8 | INSM |
INSMED Inc
|
307 | $32,732 |
All Filings in NKTR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69 | 1 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $71 | 1 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $42 | 1 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $56 | 1 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $25 | 1 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $10 | 16 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||